Baxter International Inc.

BAX

$78.15

-7.39% (1 year change)

Avg closing price

Price range

Market Cap

$41.1 Billion

The market capitalization is the market value of the company. It is the sum of the value of all outstanding shares.

Revenue

$2.72 Billion

Total revenue in the last quarter.

Net Income

$246 Million

Net income is all revenues minus all expenses including taxes and interest in the last quarter.

Earnings per Share

$1.81

Earnings per share is the amount of net income that is attributed to each single share outstanding.

Dividends per Share

$0.905 (1.12%)

Dividends per share is the amount of dividends paid out to the shareholder of a single share in the last 12 months. The percentage indicates the ratio of the company's annual dividend compared to its current price per share (stock price).

Price-Earnings Ratio

44.68x

The price-earnings ratio is the ratio between the price per share (stock price) and the earnings per share. It indicates the percentage of the price per share (stock price) that is generated in earnings in the last 12 months.

EBIT

$367 Million

Earnings before interest expenses and taxes in the last quarter.

Employees

50,000

The number of full time employees.

Revenue & Earnings

Balance Sheet

Baxter International Inc.

Baxter International, Inc. provides portfolio of essential renal and hospital products, including acute and chronic dialysis, sterile IV solutions, infusion systems and devices, parenteral nutrition therapies; premixed and oncolytic injectable, bio surgery products and anesthetics, drug reconstitution systems and pharmacy automation, software and services. It operates through the following segment: Americas, Europe, Middle East & Africa and Asia-Pacific. The company was founded by Davis Baxter in 1931 and is headquartered in Deerfield, IL.

News

Baxter International (BAX) Scheduled to Post Earnings on Thursday

Baxter International (BAX) Scheduled to Post Earnings on Thursday

Baxter International (NYSE:BAX) is scheduled to be releasing its earnings data before the market opens on Thursday, October 29th. Analysts expect Baxter International to post earnings of $0.71 per ...

Daily Political Daily Political, 8 days ago
Baxter to Present at the 29th Annual Credit Suisse Virtual Healthcare Conference

Baxter to Present at the 29th Annual Credit Suisse Virtual Healthcare Conference

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a leading global medical products company, will present at the 29th Annual Credit Suisse Virtual Healthcare Conference via we...

Business Wire Business Wire, 14 days ago
Baxter Supports New Study Showing Nutritional Needs in Critically Ill COVID-19 Patients and Published Practical Guidelines for Care

Baxter Supports New Study Showing Nutritional Needs in Critically Ill COVID-19 Patients and Published Practical Guidelines for Care

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global leader in nutrition therapy, supports interim findings of an ongoing prospective study, “Persistent Hypermetabolism ...

Business Wire Business Wire, 15 days ago